Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 16, 2023
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
Jason Gerberry Maintained (CARA) at Sell with Decreased Target to $4 on, May 16th, 2023
Jason Gerberry of B of A Securities, Maintained "Cara Therapeutics, Inc." (CARA) at Sell with Decreased Target from $6 to $4 on, May 16th, 2023.
Jason has made no other calls on CARA in the last 4 months.
There are 3 other peers that have a rating on CARA. Out of the 3 peers that are also analyzing CARA, 0 agree with Jason's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jason
- Daniel Wolle of "JP Morgan" Maintained at Buy with Decreased Target to $16 on, Tuesday, March 7th, 2023
- David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $13 on, Tuesday, March 7th, 2023
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
